2018 annual financial data

Cardiff Oncology 2018 Operating cash flow margin

Direct answer

Operating cash flow margin was -3,492.06%.

Operating income was -17,053,000 USD and net income was -16,461,000 USD.
Operating cash flow was -13,200,000 USD.

Get free Cardiff Oncology email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
378,000 USD
Operating income
-17,053,000 USD
Net income
-16,461,000 USD
Operating cash flow
-13,200,000 USD